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Synthesis and Characterization
Scheme S1. Synthesis of azides 2-8, alkyne 1, and adducts 9-15 for the in situ click chemistry.
General remarks:
1 H and 13 C NMR spectra were recorded by using TMS as the internal standard in methanol-d 4 or
CDCl 3 or DMSO-d 6 at 400 MHz and 101 MHz, respectively, with a Bruker BioSpin GmbH spectrometer. Mass spectra (MS) were recorded on a Shimadzu LCMS-2010A instrument with an ESI or ACPI mass selective detector and high resolution mass spectra (HRMS) were recorded on a Shimadzu LCMS-IT-TOF. Melting points (m.p.) were determined by using an SRS OptiMelt automated melting point instrument without correction. Flash column chromatography was performed with silica gel (200-300 mesh) purchased from Qingdao Haiyang Chemical Co. Ltd.
The purity of the synthesized compound was confirmed to be higher than 95% by using analytical HPLC performed with a dual pump Shimadzu LC-20 AB system equipped with a Ultimate XB-C18 column (4.6 × 250 mm, 5 μm) and eluted with methanol-water (80:20) containing 0.1% TFA at a flow rate of 1.0 mL/min. All chemicals were purchased from commercial sources unless otherwise specified. All the solvents were of analytical reagent grade and were used without further purification.
S3
1-(2-chloroethyl)piperidine (2): 1-(2-chloroethyl)piperidine hydrochloride (2.0 g, 10.9 mmol) and NaN 3 (2.1 g, 32.5 mmol) were dissolved in water and allowed to stir at 80 °C overnight. Then, this solution was cooled down and basified by addition of a 2 M NaOH solution, and the mixture was extracted 3 times with Et 2 O. Organic layers were collected, dried over Na 2 SO 4 and the solvent was evaporated to afford the product as a pale yellow oil (0.81 g, 48% 
4-(2-azidoethyl)morpholine (4):
4-(2-chloroethyl)morpholine hydrochloride (2.0 g, 10.9 mmol) and NaN 3 (2.1 g, 32.5 mmol) were dissolved in acetonitrile/water (1:1) and allowed to stir at 80 °C overnight. Then, this solution was cooled down and basified by addition of a 2 M NaOH solution, and the mixture was extracted 3 times with Et 2 O.
Organic layers were collected, dried over Na 2 SO 4 and the solvent was evaporated to afford the product as a brown oil (0.75 g, 44% yield).
1
H NMR (400 MHz, CDCl 3 ) δ 3.75 -3.62 (m, 4H), 3.33 (t, J = 5.9 Hz, 2H), 2.56 (t, J = 5.9
Hz, 2H), 2.52 -2.40 (m, 4H).
2-azido-N,N-dimethylethanamine (5):
2-chloro-N,N-dimethylethanamine hydrochloride (1.6 g, 10.9 mmol) and NaN 3 (2.1 g, 32.5 mmol) were dissolved in water and allowed to stir at 80 °C overnight. Then, this solution was cooled down and basified by addition of a 2 M NaOH solution, and the mixture was extracted 3 times with Et 2 O.
Organic layers were collected, dried over Na 2 SO 4 and the solvent was evaporated to afford the product as a pale yellow oil (0.53 g, 43% yield). 3-azido-N,N-dimethylpropan-1-amine (6): 3-chloro-N,N-dimethylpropan-1-amine hydrochloride (1.7 g, 10.9 mmol) and NaN 3 (2.1 g, 32.5 mmol) were dissolved in water and allowed to stir at 80 °C overnight. Then, this solution was cooled down and basified by addition of a 2 M NaOH solution, and the mixture was extracted 3 times with Et 2 O.
Organic layers were collected, dried over Na 2 SO 4 and the solvent was evaporated to afford the product as a pale yellow oil (0.59 g, 42% yield). 3-azidopropan-1-ol (7): 3-chloropropan-1-ol (2.0 mL, 23.9 mmol) was dissolved in acetonitrile (100 mL). NaN 3 (4.7 g, 71.7 mmol) was added to the solution and the mixture was stirred under reflux overnight. Acetonitrile was then removed under reduced pressure and the resulting residue was suspended in ethyl acetate (50 mL) and extracted with 0.1 N HCl (3 × 50 mL), water (3 × 50 mL) and brine (1 × 50 mL). The organic layer was dried over Na 2 SO 4 and concentrated to afford the product as a pale yellow oil (0.87 g, 36% yield).
1
H NMR (400 MHz, CDCl 3 ) δ 3.74 (t, J = 5.9 Hz, 2H), 3.61 (t, J = 6.3 Hz, 2H), 2.44 (s, 1H), 2.00 -1.89 (m, 2H).
3-azidopropanoic acid (8):
3-chloropropanoic acid (2.0 mL, 23.4 mmol) was dissolved in acetonitrile (100 mL).
NaN 3 (4.6 g, 70.2 mmol) was added to the solution and the mixture was stirred under reflux overnight. Acetonitrile was then removed under reduced pressure and the resulting residue was suspended in ethyl acetate (50 mL) and extracted with 0.1 N HCl (3 × 50 mL), water (3 × 50 mL) and brine (1 × 50 mL). The organic layer was dried over Na 2 SO 4 and then concentrated to afford the product as a pale yellow oil (1.05 g, 39% yield).
H NMR (400 MHz,
CDCl 3 ) δ 3.52 (t, J = 6.4 Hz, 2H), 2.58 (t, J = 6.4 Hz, 2H). 33, 193.77, 164.54, 162.97, 132.86, 132.34, 126.55, 124.49, 116.64, 116.04, 79.51, 78.85, 56.41 39, 193.31, 163.99, 162.61, 132.45, 132.32, 126.97, 126.40, 115.14, 114.76, 77.41, 76.48, 65.68, 55.97, 31.98, 29.59 193.87, 164.75, 163.06, 132.57, 132.40, 126.44, 125.67, 116.06, 115.64, 79.50, 78.82, 66.92, 56.43, 48.82, 46.84, 26.68, 12.11 141.41, 138.83, 129.70, 129.00, 115.21, 114.83, 109.83, 108.99, 97.06, 75.71, 75.39, 66.38, 55.89, 49.43, 47.01, 44.94, 26.90, 12.48, 11.63 .
1-(4-hydroxyphenyl)-2-(4-(prop-
General Method for 1,4-adducts synthesis via click chemistry: One mole equivalent of compound 1 (0.20 g) was dissolved in a 2:1 mixture of t-BuOH/H 2 O (3 mL). CuSO 4 ·5H 2 O (100 µL, 100 mM) and sodium ascorbate (300 µL, 100 mM) were added and the solution stirred for 10 min. The respective azide (5 mole equivalent) was added and the solution was allowed to stir overnight under 80 °C. The solvent was removed under reduced pressure and the products were purified by using flash column chromatography with CH 2 Cl 2 /MeOH (20:1) as elution solvents. .
7-(diethylamino)-3-(4-(4-(3-(diethylamino)propoxy)phenyl)-5-(4-((1-(2-(piperidin-1-yl)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1H-imidazol-2-yl)-2H-chromen-2-one (9):
7-(diethylamino)-3-(4-(4-(3-(diethylamino)propoxy)phenyl)-5-(4-((1-(3-(4-methylpiperazin-1-yl)propyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1H-imidazol-2-yl)-2H-chromen-2-one (10):
Orange solid (0.20 g, 77% yield). 141.34, 138.82, 129.70, 128.98, 122.99, 114.83, 114.70, 109.83, 108.97, 97.05, 66.36, 62.18, 55.08, 54.41, 52.95, 49.43, 48.20, 47.00, 45.97, 44.92, 27.27, 26.90, 12.46, 11.63 . 97, 155.96, 150.99, 141.34, 138.79, 129.69, 128.94, 123.35, 115.02, 114.78, 109.83, 108.89, 96.95, 66.78, 66.30, 62.05, 57.78, 53.43, 49.36, 47.43, 46.93, 44.88, 26.78, 12.45, 11.55 .
7-(diethylamino)-3-(4-(4-(3-(diethylamino)propoxy)phenyl)-5-(4-((1-(2-morpholinoethyl)-1H-
7-(diethylamino)-3-(4-(4-(3-(diethylamino)propoxy)phenyl)-5-(4-((1-(2-(dimethylamino)ethyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1H-imidazol-2-yl)-2H-chromen-2-one (12):
Orange solid (0.14 g, 62% yield). m.p. 141. 35, 138.82, 129.70, 128.98, 123.30, 114.76, 114.45, 109.85, 108.97, 97.04, 66.34, 62.18, 58.71, 49.40, 48.25, 46.97, 45.35, 44.92, 26.82, 12.47, 11.56 3-(4-(4-(3-(diethylamino)propoxy)phenyl)-5-(4-((1-(3-(dimethylamino)propyl)-1H-1,2,3 Hz, 4H), 2.72 -2.63 (m, 2H), 2.59 (q, J = 7.1 Hz, 4H), 2.32 -2.14 (m, 8H), 2.12 -2.03 (m, 2H), 2.01 -1.92 (m, 2H), 1.23 (t, J = 7.0 Hz, 6H), 1.07 (t, J = 7.1 Hz, 6H).
7-(diethylamino)-
13
C NMR (101 MHz, CDCl 3 ) δ 162. 13, 156.04, 151.00, 141.39, 138.88, 129.75, 129.02, 123.03, 114.79, 114.68, 109.84, 108.96, 97.02, 66.28, 62.15, 55.77, 49.40, 48.15, 46.95, 45.34, 44.98, 28.15, 26.62, 12.49, 11.41 . 11, 156.03, 151.04, 141.41, 138.94, 129.79, 129.03, 123.34, 115.12, 114.80, 109.86, 108.94, 97.00, 66.16, 62.10, 58.40, 49.35, 47.06, 46.89, 44.98, 32.63, 26.30, 12.49, 11.11 Hz, 1H), 6.37 (s, 1H), 4.98 (s, 2H), 4.50 -4.57 (m, 2H), 4.06 -3.82 (m, 2H), 3.53 (s, 1H), 3.42 -3.27 (m, 4H), 3.20 -3.04 (m, 6H) , 2.69 -2.76 (m, 2H), 2.20 -1.91 (m, 2H), 1.23 (t, J = 6.8 Hz, 6H), 1.10 (t, J = 6.4 Hz, 6H).
7-(diethylamino)-3-(4-(4-(3-(diethylamino)propoxy)phenyl)-5-(4-((1-(3-hydroxypropyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1H-imidazol-2-yl)-2H-chromen-2-one (14):
3-(4-((4-(2-(7-(diethylamino)-2-oxo-2H-chromen-3-yl)-4-(4-(3-(diethylamino)propoxy)phenyl)-1H-imidazol
C NMR
(101 MHz, CD 3 OD) δ 161.27, 157.87, 155.84, 151.37, 141.10, 139.25, 129.84, 128.97, 125.25, 114.42, 114.18, 109.86, 108.42, 96.18, 69.88, 64.59, 61.17, 48.72, 46.77, 44.46, 29.37, 23.53, 11.59, 7.81 Figure S1 . Table, Spectra and Graphs   Table S1 . DNA samples used in the present study. 
Name
